HLX53
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HLX53, covering 2024-12-18 to 2024-12-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients. [Phase 2]